ZyVersa Therapeutics (ZVSA) Institutional Ownership $1.22 0.00 (0.00%) Closing price 02/21/2025 03:59 PM EasternExtended Trading$1.20 -0.02 (-1.64%) As of 02/21/2025 05:15 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrends Institutional Ownership Changes (13F Filings) for ZyVersa Therapeutics (NASDAQ:ZVSA)CurrentInstitutional OwnershipPercentage3.91%Number ofInstitutional Buyers(last 12 months)1TotalInstitutional Inflows(last 12 months)$26.77KNumber ofInstitutional Sellers(last 12 months)0 Get ZVSA Insider Trade Alerts Want to know when executives and insiders are buying or selling ZyVersa Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address ZyVersa Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails2/11/2025 Virtu Financial LLC25,259$27K0.0%N/A1.079% 7/27/2023 Virtu Financial LLC120,377$30K0.0%N/A0.595% 4/17/2023 Winthrop Advisory Group LLC13,361$26K0.0%N/A0.145% (Data available from 1/1/2016 forward) ZVSA Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of ZVSA shares? During the previous two years, the following institutional investors and hedge funds held shares of ZyVersa Therapeutics shares: Virtu Financial LLC ($27K), Winthrop Advisory Group LLC ($26K).Learn more on ZVSA's institutional investors. What percentage of ZyVersa Therapeutics stock is owned by institutional investors? 3.91% of ZyVersa Therapeutics stock is owned by institutional investors. Learn more on ZVSA's institutional investor holdings. Which institutional investors have been buying ZyVersa Therapeutics stock? The following institutional investors have purchased ZyVersa Therapeutics stock in the last 24 months: Virtu Financial LLC ($145.64K), and Winthrop Advisory Group LLC ($13.36K). How much institutional buying is happening at ZyVersa Therapeutics? Institutional investors have bought a total of 158,997 shares in the last 24 months. This purchase volume represents approximately $19.40M in transactions. Related Companies PMCB Major Shareholders CHRO Major Shareholders TLPH Major Shareholders KPRX Major Shareholders KLTO Major Shareholders JAGX Major Shareholders BCLI Major Shareholders AEON Major Shareholders RLMD Major Shareholders TSBX Major Shareholders This page (NASDAQ:ZVSA) was last updated on 2/22/2025 by MarketBeat.com Staff From Our PartnersAlert: DOGE goes live"It's Elon's world, and the rest of us live in it." Every investor in America is trying to figure out what ...Altimetry | SponsoredElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | SponsoredBuy NVDA Now? After weeks of volatility, did President Trump just turn Nvidia (NVDA) into a raging BUY? The beloved chip...Chaikin Analytics | SponsoredNvidia’s Next Big Move Comes on Feb. 26Nvidia isn't the only company that benefits greatly from these earnings calls. That's because a handful of ...Weiss Ratings | SponsoredA strange twist 500 miles from WashingtonEnergy is life. And this year, it could also make national heroes out of President Trump and VP Vance. ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ZyVersa Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share ZyVersa Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
